Genomtec S.A. Strategic Asset Allocation Index
Genomtec S.A. strategic asset allocation index. Genomtec S.A. (GMT) has a Strategic Asset Allocation Index of 15.1% as of June 2023. Strategic assets (PP&E of zł2.00 Million plus long-term investments of zł-) total zł2.00 Million, measured against net assets of zł13.22 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Genomtec S.A. to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Genomtec S.A. (2020–2021)
Strategic asset allocation index of Genomtec S.A. from 2020 to 2021. This chart shows how Genomtec S.A.'s Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of June 2023, the index stands at 15.1%, representing strategic assets of zł2.00 Million against net assets of zł13.22 Million PLN. Check tangible equity quality of Genomtec S.A. to evaluate the tangible quality of the company's equity base.
Genomtec S.A. Strategic Asset Allocation Index by Year (2020–2021)
Genomtec S.A. strategic asset allocation index by year from 2020 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Genomtec S.A. from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Genomtec S.A. (GMT) total market value.
| Year | SAAI | Strategic Assets (PLN) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 258.5% | zł1.91 Million | zł1.91 Million | zł- | zł738.00K | ▲ +242.2 pp |
| 2020 | 16.4% | zł1.24 Million | zł1.24 Million | zł- | zł7.57 Million | — |